Breast cancer stands as a paramount public health concern worldwide, underscoring an imperative necessity within the research sphere for precision-driven and efficacious methodologies facilitating accurate detection. The existing diagnostic approaches in breast cancer often suffer from limitations in accuracy and efficiency, leading to delayed detection and subsequent challenges in personalized treatment planning. The primary focus of this research is to overcome these shortcomings by harnessing the power of advanced deep learning techniques, thereby revolutionizing the precision and reliability of breast cancer classification. This research addresses the critical need for improved breast cancer diagnostics by introducing a novel Convolutional Neural Network (CNN) model integrated with an Early Stopping callback and ReduceLROnPlateau callback. By enhancing the precision and reliability of breast cancer classification, the study aims to overcome the limitations of existing diagnostic methods, ultimately leading to better patient outcomes and reduced mortality rates. The comprehensive methodology includes diverse datasets, meticulous image preprocessing, robust model training, and validation strategies, emphasizing the model's adaptability and reliability in varied clinical contexts. The findings showcase the CNN model's exceptional performance, achieving a 95.2% accuracy rate in distinguishing cancerous and non-cancerous breast tissue in the integrated dataset, thereby demonstrating its potential for enhancing clinical decision-making and fostering the development of AI-driven diagnostic solutions.

Alzheimer's disease (AD) is a debilitating neurological condition marked by memory loss and an ongoing decrease in cognitive function. Timely management and enhanced patient outcomes are contingent upon an early and precise diagnosis. Deep learning has become an effective technique for AD classification. With the use of picture augmentation techniques and convolutional neural networks (CNNs), it suggests a unique deep learning framework for AD diagnosis. The methodology provides intuitive visualizations of individual vulnerability by creating high resolution (HR) diseases probability diagrams from local brain regions in magnetic resonance imaging (MRI) data. Previous research based on CNNs, and pre-trained models show the promise of deep learning for AD classification, obtaining over 90% accuracy as well as F1 score for all AD phases. Using Convolutional Neural Networks (CNNs) and picture augmentation techniques on an augmented dataset, this research presents a unique deep learning framework for diagnosing AD and distinguishing four stages of the disease: moderate, non-demented, mild, and very mild. This framework is effective in accurately diagnosing AD phases, as proven by its remarkable 94.6% accuracy. In addition, the framework produces high-resolution disease probability maps, which is a major improvement over current techniques and offers clear visualizations of individual risk.